| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/26/1997 | US5661001 High molecular weight desulphatohirudin |
| 08/26/1997 | US5660997 Contacting sample with sex-associated membrane protein which specifically binding to any antibodies to form a complex, detecting said antibody to above protein by contacting complex with an antibody which binds immunoglobulin |
| 08/26/1997 | US5660986 Immortalized human cell lines containing exogenous cytochrome P450 genes |
| 08/26/1997 | US5660983 Maize cytoplasmic male sterility type T (cms-T) mitochondria DNA |
| 08/26/1997 | US5660834 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates |
| 08/26/1997 | US5660825 Treating autoimmune disorders by administering protein complex deactivator |
| 08/26/1997 | US5660824 Muscle trophic factor |
| 08/26/1997 | US5660812 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 08/26/1997 | US5660692 Method of crosslinking amino acid-containing polymers using photoactivatable chemical crosslinkers |
| 08/26/1997 | CA1339389C Purified protein a compositions and methods for their preparation |
| 08/26/1997 | CA1339388C Atrial hypotensive peptide having 46 amino acids |
| 08/26/1997 | CA1339387C Magainins-synthetic antimicrobial compounds |
| 08/26/1997 | CA1339365C Oligopeptides and intermediates and processes for their manufacture |
| 08/26/1997 | CA1339363C Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
| 08/26/1997 | CA1339361C Adult t cell leukemia virus antigen polypeptide |
| 08/26/1997 | CA1339359C Hybrid protein and fused gene encoding gene |
| 08/26/1997 | CA1339358C Process for the preparation of motilin-like polypeptide and expression thereof |
| 08/26/1997 | CA1339357C Gap gene sequences and diagnostic uses thereof |
| 08/26/1997 | CA1339356C Human platelet-derived growth factor receptor |
| 08/26/1997 | CA1339354C Recombinant retroviruses with amphotropic and ecotropic host ranges |
| 08/26/1997 | CA1339346C Recombinant chimeric vaccine |
| 08/21/1997 | WO1997030178A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | WO1997030166A1 Microspore-specific promoter from tobacco |
| 08/21/1997 | WO1997030163A1 Plants having enhanced nitrogen assimilation/metabolism |
| 08/21/1997 | WO1997030161A1 Hybrid proteins which form heterodimers |
| 08/21/1997 | WO1997030159A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | WO1997030158A2 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | WO1997030157A1 Novel human myeloid terminal differentiation response gene |
| 08/21/1997 | WO1997030155A1 Gene therapy method using fgf-5 |
| 08/21/1997 | WO1997030154A1 Nucleotide sequence from goat liver |
| 08/21/1997 | WO1997030153A1 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 08/21/1997 | WO1997030151A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation |
| 08/21/1997 | WO1997030150A2 Molecules for the induction of immunological tolerance |
| 08/21/1997 | WO1997030149A1 Novel era |
| 08/21/1997 | WO1997030108A1 Characterized brca1 and brca2 proteins and screening and therapeutic methods based on characterized brca1 and brca2 proteins |
| 08/21/1997 | WO1997030089A1 Novel antibody-cytokine fusion protein, and methods of making and using the same |
| 08/21/1997 | WO1997030088A2 Methods of treating vascular disease with tnf antagonists |
| 08/21/1997 | WO1997030086A1 Nucleotide sequence typical for a deletion of proto-oncogene ret in exon 11 |
| 08/21/1997 | WO1997030085A1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 08/21/1997 | WO1997030084A1 Tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 08/21/1997 | WO1997030083A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
| 08/21/1997 | WO1997030082A2 Antifungic and antibacterial peptide |
| 08/21/1997 | WO1997030081A1 Ebna2 peptides and methods of using same |
| 08/21/1997 | WO1997030079A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 08/21/1997 | WO1997030074A1 Isolation and use of sh3 binding peptides |
| 08/21/1997 | WO1997030072A1 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 08/21/1997 | WO1997030070A1 Novel compounds |
| 08/21/1997 | WO1997030065A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | WO1997030024A2 Lipids and their use, for example, in liposomes |
| 08/21/1997 | WO1997029781A1 Methods and compositions for modulating an immune response |
| 08/21/1997 | WO1997029772A1 Recombinant canine herpesviruses |
| 08/21/1997 | WO1997029771A1 Immunogenic detoxified mutants of cholera toxin |
| 08/21/1997 | WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/21/1997 | WO1997029765A1 Antimicrobial peptides and methods of use |
| 08/21/1997 | WO1997029761A1 Method of producing bone-inducing agent |
| 08/21/1997 | WO1997029635A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 08/21/1997 | WO1997022972A3 Method for the simultaneous detection of a therapeutic target for a disease state and its neutralizing antibody-like molecule |
| 08/21/1997 | WO1997017369A3 Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector |
| 08/21/1997 | WO1997014806A3 Delivery of biologically active polypeptides |
| 08/21/1997 | CA2247246A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/21/1997 | CA2246712A1 Cytokine expressed by dia/lif-deficient embryonic stem cells for the inhibition of differentiation |
| 08/21/1997 | CA2246578A1 Novel human myeloid terminal differentiation response gene |
| 08/21/1997 | CA2246362A1 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 08/21/1997 | CA2246223A1 Nucleotide sequence from goat liver |
| 08/21/1997 | CA2245877A1 Hybrid proteins which form heterodimers |
| 08/21/1997 | CA2245761A1 Microspore-specific promoter from tobacco |
| 08/21/1997 | CA2245727A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | CA2245518A1 Antifungic and antibacterial peptide |
| 08/21/1997 | CA2245503A1 Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions |
| 08/21/1997 | CA2244800A1 Immunogenic detoxified mutants of cholera toxin |
| 08/21/1997 | CA2243662A1 Recombinant canine herpesviruses |
| 08/21/1997 | CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof |
| 08/21/1997 | CA2243549A1 Nucleotide sequence typical for a deletion of proto-oncogene ret in exon 11 |
| 08/21/1997 | CA2242660A1 Antimicrobial peptides and methods of use |
| 08/21/1997 | CA2241802A1 Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 08/21/1997 | CA2218378A1 Peptide antagonists of cellular mitogenesis and motogenesis and their therapeutic use |
| 08/21/1997 | CA2197847A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of borna disease virus, nucleic acid fragments coding therefor and their use for diagnostic and immunization purposes |
| 08/20/1997 | EP0790316A2 Emulsifier from yeast |
| 08/20/1997 | EP0790311A1 Microspore-specific promoter from tobacco |
| 08/20/1997 | EP0790309A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790308A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0790307A1 Molecular cloning and expression of human IL-3 |
| 08/20/1997 | EP0790306A2 Tumor necrosis factor (tnf) inhibitor and use thereof |
| 08/20/1997 | EP0790305A1 Mutant human growth hormones and their uses |
| 08/20/1997 | EP0790255A2 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
| 08/20/1997 | EP0789844A1 The use of a bmp protein receptor complex for screening bone metabolism actives and cells co-transfected with a type ii bmp receptor and a type i bmp receptor |
| 08/20/1997 | EP0789783A1 Antigen binding peptides (abtides) from peptide libraries |
| 08/20/1997 | EP0789776A1 Nucleic acid transfer system |
| 08/20/1997 | EP0789774A2 Enhanced immune response by introduction of cytokine gene and/or costimulatory molecule b7 gene in a recombinant virus expressing system |
| 08/20/1997 | EP0789773A1 Processes for modifying plant flowering behaviour |
| 08/20/1997 | EP0789768A1 Respiratory syncytial virus protein g expressed on bacterial membrane |
| 08/20/1997 | EP0789767A1 Purified papillomavirus proteins |
| 08/20/1997 | EP0789766A1 Chimeric papillomavirus-like particles |
| 08/20/1997 | EP0789765A1 Genetic control of flowering |
| 08/20/1997 | EP0789764A1 A novel family of protease inhibitors, and other biologic active substances |
| 08/20/1997 | EP0789763A1 Icam-4 materials and methods |
| 08/20/1997 | EP0789762A1 Methods for the diagnosis of glaucoma |
| 08/20/1997 | EP0789761A1 Human scf, a splice variant thereof, its pharmaceutical use |